Evidence map›Paper›PMID 35116343›Full record

ArticleTranslational cancer research2021

Effect of monocarboxylate transporter-1 on the biological behavior of iodine-refractory thyroid carcinoma.

Qian Li, Bin Xu, Yunxiang Tang, Yuxia Li, Hong Ying

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Acetate Metabolism in Thyroid Cancer Progression.International journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qian LiDepartment of Nuclear Medicine, Chongqing University Central Hospital/Chongqing Emergency Medical Center, Chongqing, China.
Bin XuDepartment of Nuclear Medicine, Chongqing University Central Hospital/Chongqing Emergency Medical Center, Chongqing, China.
Yunxiang TangDepartment of Nuclear Medicine, Chongqing University Central Hospital/Chongqing Emergency Medical Center, Chongqing, China.
Yuxia LiDepartment of Nuclear Medicine, Chongqing University Central Hospital/Chongqing Emergency Medical Center, Chongqing, China.
Hong YingDepartment of Nuclear Medicine, Chongqing University Central Hospital/Chongqing Emergency Medical Center, Chongqing, China.
Chongqing Emergency Medical Center · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferentiated thyroid cancer (DTC) is the most common thyroid tumor, and the cells of DTC patients can lose the ability to differentiate in their natural state or during treatment and develop radioiodine-refractory DTC (RAI-R DTC), resulting in increased malignancy. Monocarboxylate transporter-1 (

methodsData from 14 iodine-refractory thyroid carcinoma patients were collected, and the effective radioiodine treatment group was used as the control group. The expression of

resultsCompared to radioiodine-sensitive DTC (RAI-DTC), which was responded to iodine treatment,

conclusionsThe expression of

Indexed as

invasioniodine-refractory differentiated thyroid cancer (DTC)metastasisMonocarboxylate transporter-1 (MCT1)

Identifiers

PMID35116343
PMCPMC8797869
OpenAlexW3216366891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.